Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1380312-09-3

C31H35N5O4 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1380312-09-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1380312-09-3 Structure

  • Basic information

    1. Product Name: C31H35N5O4
    2. Synonyms: C31H35N5O4
    3. CAS NO:1380312-09-3
    4. Molecular Formula:
    5. Molecular Weight: 541.65
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1380312-09-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C31H35N5O4(CAS DataBase Reference)
    10. NIST Chemistry Reference: C31H35N5O4(1380312-09-3)
    11. EPA Substance Registry System: C31H35N5O4(1380312-09-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1380312-09-3(Hazardous Substances Data)

1380312-09-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1380312-09-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,0,3,1 and 2 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1380312-09:
(9*1)+(8*3)+(7*8)+(6*0)+(5*3)+(4*1)+(3*2)+(2*0)+(1*9)=123
123 % 10 = 3
So 1380312-09-3 is a valid CAS Registry Number.

1380312-09-3Relevant articles and documents

SUBSTITUTED BENZOPYRAZIN DERIVATIVES AS FGFR KINASE INHIBITORS FOR THE TREATMENT OF CANCER DISEASES

-

, (2012/06/16)

The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1380312-09-3